Involvement of a Multidrug Efflux Pump and Alterations in Cell Surface Structure in the Synergistic Antifungal Activity of Nagilactone E and Anethole against Budding Yeast <i>Saccharomyces cerevisiae</i>

Nagilactone E, an antifungal agent derived from the root bark of <i>Podocarpus nagi</i>, inhibits 1,3-β glucan synthesis; however, its inhibitory activity is weak. Anethole, the principal component of anise oil, enhances the antifungal activity of nagilactone E. We aimed to determine the...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Ueda (Author), Yuhei O. Tahara (Author), Makoto Miyata (Author), Akira Ogita (Author), Yoshihiro Yamaguchi (Author), Toshio Tanaka (Author), Ken-ichi Fujita (Author)
Format: Book
Published: MDPI AG, 2021-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ba4fcb4af4a642e48a9833aade1707f1
042 |a dc 
100 1 0 |a Yuki Ueda  |e author 
700 1 0 |a Yuhei O. Tahara  |e author 
700 1 0 |a Makoto Miyata  |e author 
700 1 0 |a Akira Ogita  |e author 
700 1 0 |a Yoshihiro Yamaguchi  |e author 
700 1 0 |a Toshio Tanaka  |e author 
700 1 0 |a Ken-ichi Fujita  |e author 
245 0 0 |a Involvement of a Multidrug Efflux Pump and Alterations in Cell Surface Structure in the Synergistic Antifungal Activity of Nagilactone E and Anethole against Budding Yeast <i>Saccharomyces cerevisiae</i> 
260 |b MDPI AG,   |c 2021-05-01T00:00:00Z. 
500 |a 10.3390/antibiotics10050537 
500 |a 2079-6382 
520 |a Nagilactone E, an antifungal agent derived from the root bark of <i>Podocarpus nagi</i>, inhibits 1,3-β glucan synthesis; however, its inhibitory activity is weak. Anethole, the principal component of anise oil, enhances the antifungal activity of nagilactone E. We aimed to determine the combinatorial effect and underlying mechanisms of action of nagilactone E and anethole against the budding yeast <i>Saccharomyces cerevisiae</i>. Analyses using gene-deficient strains showed that the multidrug efflux pump <i>PDR5</i> is associated with nagilactone E resistance; its transcription was gradually restricted in cells treated with the drug combination for a prolonged duration but not in nagilactone-E-treated cells. Green-fluorescent-protein-tagged Pdr5p was intensively expressed and localized on the plasma membrane of nagilactone-E-treated cells but not in drug-combination-treated cells. Quick-freeze deep-etch electron microscopy revealed the smoothening of intertwined fiber structures on the cell surface of drug-combination-treated cells and spheroplasts, indicating a decline in cell wall components and loss of cell wall strength. Anethole enhanced the antifungal activity of nagilactone E by enabling its retention within cells, thereby accelerating cell wall damage. The combination of nagilactone E and anethole can be employed in clinical settings as an antifungal, as well as a food preservative to restrict food spoilage. 
546 |a EN 
690 |a antifungal 
690 |a nagilactone E 
690 |a drug resistance 
690 |a multidrug efflux pump 
690 |a quick-freeze deep-etch electron microscopy 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 10, Iss 5, p 537 (2021) 
787 0 |n https://www.mdpi.com/2079-6382/10/5/537 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/ba4fcb4af4a642e48a9833aade1707f1  |z Connect to this object online.